brimonidine


Also found in: Wikipedia.

brimonidine

 [brĭ-mo´nĭ-dēn]
an alpha-adrenergic receptor agonist used as the tartrate salt in treatment of open-angle glaucoma and ocular hypertension; administered topically to the conjunctiva.

brimonidine

/bri·mo·ni·dine/ (brĭ-mo´nĭ-dēn) an α agonist used as the tartrate salt in the treatment of open-angle glaucoma and ocular hypertension.

brimonidine

[bri-mō′ni-dēn]
an alpha-adrenergic receptor agonist used as the tartrate salt in treatment of open-angle glaucoma and ocular hypertension. It is administered topically to the conjunctiva.

brimonidine

A drug used in the form of eyedrops in the treatment of GLAUCOMA. The drug may be used when beta-blocker eyedrops are medically undesirable or when they are inadeqately effective in controlling the glaucoma. A brand name is Alphagan.

brimonidine

an alpha2-adrenergic receptor agonist used topically to reduce intraocular pressure in the treatment of glaucoma.
References in periodicals archive ?
Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.
3 Brimonidine Tartrate (Allergan): Possible Efficacy with Longer Duration of Action 5.
The active ingredient, brimonidine, restricts excessive blood flow to the upper layers of the skin.
Shinkai said she was encouraged by preliminary data on treating rosacea indirectly by using off-label rifaximin for small intestinal bacterial overgrowth and by a new formulation of brimonidine approved in August as the first topical agent for the erythema of rosacea.
16) The side-effects included lethargy, difficulty to rouse, bradycardia and shallow respiration with decreased oxygen saturation of 8--10 hours, which are similar to those with topical brimonidine.
A therapy with idebenone (270 mg/day) and brimonidine (2 drops, 3times/day) was initiated (Mashima et al.
My wife has been using Cosopt, Xalatan, and brimonidine to treat glaucoma.
Another drug in this class is brimonidine (Alphagan).
NASDAQ: HITK), a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan[R] ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
2]) selective agonists involves reduction of aqueous humour production and brimonidine also increases uveoscleral outflow.
is the proprietary name endorsed by the European Medicines Agency (EMA) for brimonidine.
The patients were randomized to once-daily brimonidine tartrate gel 0.